We, Beijing Strong Biotechnologies, Inc. (hereinafter referred to as BSBE) is a rapid growth enterprise and focusing on R&D, manufacturing and sales of in-vitro diagnostics (IVD) products which reach to international advanced level. BSBE was registered in Zhongguancun, Beijing with the registered capital of RMB499,674,626 and successfully listed on GEM in Shenzhen with the stock code 300406 on Oct 30th, 2014.
As a Chinese leader in IVD filed, BSBE established its own R&D center and 62 R&D staffs commit to adopting advanced technology to the products, which delivers a full range of clinical biochemistry reagents over 138 analytes covering renal panel, liver panel, lipid panel,etc. The research innovation ability has been fully recognized by the government and experts in IVD field. Since 2011, BSBE has participated in Nation’s 863 projects (Highest China National R&D Program) for two subjects. Moreover, HCY, K (Enzymatic) and NGAL reagents were selected to the National Torch Program Project, meanwhile 26 products and technologies were granted and 13 patents are pending by the State Intellectual Property Office.
In recent years, BSBE has always achieved rapid development, the sales and profitability keeps 23% increase annually in last seven years which comes out in the front among the competitors in Chinese IVD field.
Until now, BSBE has established 18 offices covering the whole China. Our products not only have good reputation and 80% market coverage in tertiary Grade A hospitals in China, but also are exported to 20 countries and regions which are: Philippines, Brazil, India, Australia, UK, USA, Vietnam, Japan, Ireland, Germany, Italy, Turkey, Korea, Egypt, Nigeria, Sri Lanka, Singapore, Hong Kong.
Since 2013, BSBE has established strategic cooperation relationship with the domestic and international well-known enterprises, such as Abbott, Roche, Mindray, WEGO. BSBE always adheres to the mission of strengthening national brand, providing higher quality products and better service to customers.
